Medical Research News

RSS

Study highlights the need for better nutrition tracking in NICUs

During daily rounds in the neonatal intensive care unit (NICU), physicians need to balance many considerations in their decision-making about nutrition plans for premature infants.

9 Nov 2026

Minor sleep loss increases risk of phishing scam traps

Nearly a third of adults in the U.S. do not get enough sleep. A recent surge in attention to this issue raises serious concerns about its long-term health implications, and new research suggests that it can lead to hazardous outcomes, especially in the context of "phishing" emails.

9 Nov 2026

Animal study raises questions about semaglutide safety during pregnancy

They're the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilos.

9 Nov 2026

Survey shows Americans miss key everyday fall risk factors

A fear of falling may cause people to avoid stairs, exercise and other daily activities. But that fear can also increase the risk of a fall.

9 Nov 2026

Blocking complement factor B halts pancreatic cancer growth

Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology, published by Elsevier, demonstrates that blocking complement factor B (CFB), a pivotal enzyme in the alternative complement pathway, halts cancer growth and alters the tumor microenvironment.

9 Nov 2026

Could a single brain scan reveal how quickly your body is aging?

Researchers examined whether DunedinPACNI, an MRI-derived measure of brain aging, was associated with blood-based indicators of biological aging in 746 adults across two independent midlife cohorts. Faster DunedinPACNI was associated with higher levels of multisystem biological aging in both cohorts and greater changes in aging-related blood biomarkers over 7–15 years in a longitudinal subgroup of 224 participants.

9 Nov 2026

Five AI models tackled 227 pharmacy exam questions. Here's where they struggled

Researchers evaluated five large language models using 227 infectious disease-related pharmacy examination questions and found that all achieved approximately 90% accuracy, with ChatGPT-4o-mini scoring highest at 91.2%. Accuracy was significantly lower for medicinal chemistry, clinical microbiology, higher-order cognitive questions, and image-containing questions, raising concerns about relying on AI-generated answers without independent verification.

9 Nov 2026

Space station study tests colorectal cancer tumor avatars in microgravity

Researchers from Wake Forest Institute for Regenerative Medicine (WFIRM) are studying how microgravity affects how models of colorectal cancer cells respond to chemotherapy aboard the International Space Station.

9 Nov 2026

Liver transplants dramatically extend survival for alcohol-associated liver disease

People with alcohol-associated liver disease who received a liver transplant survived years longer than those who did not, but there are disparities in which patients receive a transplant.

9 Nov 2026

Monthly binge drinking increases advanced liver fibrosis risk in women

Women who consume four or more alcohol drinks on a single occasion once a month or more have increased odds of advanced liver fibrosis, a new study suggests.

9 Nov 2026

Blood biomarker tracks nerve damage from oxaliplatin-containing adjuvant chemotherapy

Oxaliplatin can cause numbness, tingling, and pain in the hands and feet, with consequences for mobility, work, and quality of life.

9 Nov 2026

Study reveals how astrocytes regulate brain blood flow and activity

What happens in our brains when we experience sensory stimulation? During everyday activities such as jogging, reading, or listening to music, sensory inputs activate neurons in specific brain regions.

9 Nov 2026

Cannabis use increases mortality risk in alcohol-associated hepatitis patients

People with alcohol-associated hepatitis are more likely to die from the disease if they use cannabis. A large multinational study just published in Alcohol: Clinical and Experimental Research is the first to identify active substance use, particularly cannabis use, by patients as an independent predictor of death in patients with alcohol-associated hepatitis.

9 Nov 2026

Childhood cancer cells shape-shift to spread without genetic mutations

Researchers at the University of East Anglia (UK) have proposed an explanation for why some childhood tumors spread aggressively around the body despite having relatively few genetic faults.

9 Nov 2026

Stanford study challenges long-held dogma on causes of concussions

Concussions - essentially mild traumatic brain injuries - are among the most common injuries sustained on athletic fields. In the U.S., an estimated 3.8 million sports-related concussions occur every year.

9 Nov 2026

Could a daily supplement keep blood vessels healthier as we age?

The study highlights a multi-compound nutritional supplement's potential to improve blood vessel function and lower blood pressure, aiding vascular health.

9 Nov 2026

New mRNA therapy reawakens heart muscle cells to repair damage

Scientists have developed a treatment that 'reawakens' heart muscle cells so they start to divide and help repair damaged muscle.

9 Nov 2026

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight's Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum's PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum's lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

From Qureight 9 Nov 2026

Better reimbursement programs can improve access to cancer clinical trials

New research reveals that participating in cancer clinical trials can cause financial burdens that are shaped by both socioeconomic and logistical factors.

9 Nov 2026

Modified zinc finger protein reduces brain plaques in Alzheimer's mice

A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease.

9 Nov 2026